Related references
Note: Only part of the references are listed.Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia
Qing Zhou et al.
BLOOD (2011)
Phosphotyrosine-Dependent Coupling of Tim-3 to T-Cell Receptor Signaling Pathways
Judong Lee et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Regulation of human NK-cell cytokine and chemokine production by target cell recognition
Cyril Fauriat et al.
BLOOD (2010)
Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia
Sarah Cooley et al.
BLOOD (2010)
T-bet, a Th1 transcription factor regulates the expression of Tim-3
Ana C. Anderson et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B
Ying Ju et al.
JOURNAL OF HEPATOLOGY (2010)
T Cell/Transmembrane, Ig, and Mucin-3 Allelic Variants Differentially Recognize Phosphatidylserine and Mediate Phagocytosis of Apoptotic Cells
Rosemarie H. DeKruyff et al.
JOURNAL OF IMMUNOLOGY (2010)
Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia
Sarah Cooley et al.
BLOOD (2009)
Blockade of Tim-3 Pathway Ameliorates Interferon-γ Production from Hepatic CD8+ T Cells in a Mouse Model of Hepatitis B Virus Infection
Ying Ju et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2009)
Galectin-9 expands unique macrophages exhibiting plasmacytoid dendritic cell-like phenotypes that activate NK cells in tumor-bearing mice
Atsuya Nobumoto et al.
CLINICAL IMMUNOLOGY (2009)
Human Pregnancy Up-Regulates Tim-3 in Innate Immune Cells for Systemic Immunity
Jie Zhao et al.
JOURNAL OF IMMUNOLOGY (2009)
Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis
Masako Seki et al.
CLINICAL IMMUNOLOGY (2008)
The regulation of NK cell function and development
Jin Woong Chung et al.
FRONTIERS IN BIOSCIENCE (2008)
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection
R. Brad Jones et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Galectin-9 Increases Tim-3+ Dendritic Cells and CD8+ T Cells and Enhances Antitumor Immunity via Galectin-9-Tim-3 Interactions
Keiko Nagahara et al.
JOURNAL OF IMMUNOLOGY (2008)
Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells
Ana C. Anderson et al.
SCIENCE (2007)
The Tim-3 ligand galectin-9 negatively regulates CD8+ alloreactive T cell and prolongs survival of skin graft
Feng Wang et al.
CELLULAR IMMUNOLOGY (2007)
Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function
Sheng Xiao et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Human natural killer cell development
Aharon G. Freud et al.
IMMUNOLOGICAL REVIEWS (2006)
IL-23 promotes tumour incidence and growth
John L. Langowski et al.
NATURE (2006)
Evaluation of ex vivo expanded human NK cells on antileukemia activity in SCID-beige mice
F Guimaraes et al.
LEUKEMIA (2006)
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
C Zhu et al.
NATURE IMMUNOLOGY (2005)
Negative regulation of natural killer cell function by EAT-2, a SAP-related adaptor
R Roncagalli et al.
NATURE IMMUNOLOGY (2005)
Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn
C Bloch-Queyrat et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244)
P Eissmann et al.
BLOOD (2005)
NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations:: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect
S Nguyen et al.
BLOOD (2005)
A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells
ND Huntington et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
T cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis
M Khademi et al.
JOURNAL OF IMMUNOLOGY (2004)
Interleukin-12 and the regulation of innate resistance and adaptive immunity
G Trinchieri
NATURE REVIEWS IMMUNOLOGY (2003)
Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance
CA Sabatos et al.
NATURE IMMUNOLOGY (2003)
Functional significance of the perforin/granzyme cell death pathway
JA Trapani et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Role of galectins in inflammatory and immunomodulatory processes
GA Rabinovich et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2002)
Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect
SS Farag et al.
BLOOD (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
L Monney et al.
NATURE (2002)
2B4 (CD244)-mediated activation of cytotoxicity and IFN-γ release in human NK cells involves distinct pathways
SS Chuang et al.
JOURNAL OF IMMUNOLOGY (2001)
The biology of natural killer cells in cancer, infection, and pregnancy
JS Miller
EXPERIMENTAL HEMATOLOGY (2001)
Share Paper
